| 摘要 |
A formulation for pharmaceutical or nutritional use which is prepared from: an eicosapentaenoic acid (EPA) preparation containing more than 90% EPA and less than 5% docosahexaenoic acid (DHA) and less than 5% linoleic acid; and ubiquinone in any appropriate assimilable form. The use of the formulation in the preparation of a medicament for the treatment of: cancer; any form of psychiatric disease including schizophrenia, schizoaffective disorders, schizotypy, depression, anxiety, bipolar disorder, mania, borderline personality disorder, alcoholism and attention deficit hyperactivity disorder or any other psychiatric illness; any form of neurological or neurodegenerative disease including Parkinson's disease, Alzheimer's disease, Huntington's disease or any other 'triplet repeat" disease, amyotrophic lateral sclerosis, stroke, multi-infarct or other form of dementia, multiple sclerosis, chronic fatigue and epilepsy; any form of inflammatory disease including any form of arthritis, any form of inflammatory skin disease including psoriasis and eczma, asthma, any form of inflammatory gastrointestinal disease including ulcerative colitis and Crohn's disease and any inflammatory conditions of any other organs including the eyes and brain; any for of cardiovascular or cerebrovascular disease; any form of respiratory disease; any form of metabolic disease including diabetes, syndrome X and any disturbance of calcium metabolism including osteoporosis, urolithiasis or urinary tract stone formation; any form of renal or urinary tract disease; any form of disease or disorder of the reproductive system or menstrual cycle; any disease or disorder characterized by abnormal and painful muscle contractions. |
